R87.61 - Abnormal cytological findings in specimens from cervix uteri
|Short Description:||Abnormal cytological findings in specimens from cervix uteri|
|Long Description:||Abnormal cytological findings in specimens from cervix uteri|
|Status:||Not Valid for Submission|
R87.61 is a non-specific and non-billable ICD-10 code code, consider using a code with a higher level of specificity for a diagnosis of abnormal cytological findings in specimens from cervix uteri. The code is not specific and is NOT valid for the year 2023 for the submission of HIPAA-covered transactions. Category or Header define the heading of a category of codes that may be further subdivided by the use of 4th, 5th, 6th or 7th characters.
According to ICD-10-CM guidelines this code should not to be used as a principal diagnosis code when a related definitive diagnosis has been established.
Specific Coding for Abnormal cytological findings in specimens from cervix uteri
Non-specific codes like R87.61 require more digits to indicate the appropriate level of specificity. Consider using any of the following ICD-10 codes with a higher level of specificity when coding for abnormal cytological findings in specimens from cervix uteri:
- BILLABLE CODE - Use R87.610 for Atypical squamous cells of undetermined significance on cytologic smear of cervix (ASC-US)
- BILLABLE CODE - Use R87.611 for Atypical squamous cells cannot exclude high grade squamous intraepithelial lesion on cytologic smear of cervix (ASC-H)
- BILLABLE CODE - Use R87.612 for Low grade squamous intraepithelial lesion on cytologic smear of cervix (LGSIL)
- BILLABLE CODE - Use R87.613 for High grade squamous intraepithelial lesion on cytologic smear of cervix (HGSIL)
- BILLABLE CODE - Use R87.614 for Cytologic evidence of malignancy on smear of cervix
- BILLABLE CODE - Use R87.615 for Unsatisfactory cytologic smear of cervix
- BILLABLE CODE - Use R87.616 for Satisfactory cervical smear but lacking transformation zone
- BILLABLE CODE - Use R87.618 for Other abnormal cytological findings on specimens from cervix uteri
- BILLABLE CODE - Use R87.619 for Unspecified abnormal cytological findings in specimens from cervix uteri
Tabular List of Diseases and Injuries
The Tabular List of Diseases and Injuries is a list of ICD-10 codes, organized "head to toe" into chapters and sections with coding notes and guidance for inclusions, exclusions, descriptions and more. The following references are applicable to this diagnosis code:
Type 1 ExcludesType 1 Excludes
A type 1 excludes note is a pure excludes note. It means "NOT CODED HERE!" An Excludes1 note indicates that the code excluded should never be used at the same time as the code above the Excludes1 note. An Excludes1 is used when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.
- abnormal cytological findings in specimens from other female genital organs R87.69
- abnormal cytological findings in specimens from vagina R87.62
- carcinoma in situ of cervix uteri histologically confirmed D06
- cervical intraepithelial neoplasia I CIN I N87.0
- cervical intraepithelial neoplasia II CIN II N87.1
- cervical intraepithelial neoplasia III CIN III D06
- dysplasia mild moderate of cervix uteri histologically confirmed N87
- severe dysplasia of cervix uteri histologically confirmed D06
Type 2 ExcludesType 2 Excludes
A type 2 excludes note represents "Not included here". An excludes2 note indicates that the condition excluded is not part of the condition represented by the code, but a patient may have both conditions at the same time. When an Excludes2 note appears under a code, it is acceptable to use both the code and the excluded code together, when appropriate.
Cervical Cancer Screening
The cervix is the lower part of the uterus, the place where a baby grows during pregnancy. Cancer screening is looking for cancer before you have any symptoms. Cancer found early may be easier to treat.
Cervical cancer screening is usually part of a woman's health checkup. There are two types of tests: the Pap test and the HPV test. For both, the doctor or nurse collects cells from the surface of the cervix. With the Pap test, the lab checks the sample for cancer cells or abnormal cells that could become cancer later. With the HPV test, the lab checks for HPV infection. HPV is a virus that spreads through sexual contact. It can sometimes lead to cancer. If your screening tests are abnormal, your doctor may do more tests, such as a biopsy.
Cervical cancer screening has risks. The results can sometimes be wrong, and you may have unnecessary follow-up tests. There are also benefits. Screening has been shown to decrease the number of deaths from cervical cancer. You and your doctor should discuss your risk for cervical cancer, the pros and cons of the screening tests, at what age to start being screened, and how often to be screened.
[Learn More in MedlinePlus]
- FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
- FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
- FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
- FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
- FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
- FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
- FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
- FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016 (First year ICD-10-CM implemented into the HIPAA code set)